News

Cell Therapeutics said that the proposed trial design is to test two different dosing schedules of Pixantrone. Patients on the trial are expected to be randomised to receive

Strides said that Vecuronium is a nondepolarising neuromuscular blocking agent claimed to possess all of the characteristic pharmacological actions of this class of drugs (curariform). Vecuronium is about

RGN-352 is an injectable formulation of the novel therapeutic peptide Thymosin beta 4, or Tß4, for patients who have suffered an acute myocardial infarction, or AMI or heart

Shire said that the lawsuit results from an abbreviated new drug application (ANDA) filed by Actavis for generic versions of 1mg, 2mg, 3mg and 4mg guanfacine hydrochloride extended

Boston Scientific Taxus Element Stent System incorporates a platinum chromium alloy with a new stent design and an advanced catheter delivery system. The company plans to launch the

Aeterna Zentaris has posted a net loss of $5.9m for the first quarter of 2010, or $0.09 per diluted share, compared to $12.4m, or $0.23 per diluted share,

eClinicalWorks’ unified solutions allow patient data to be shared within a network of physicians, while streamlining workflow, enhancing charge capture and eliminating the paper charts. More than 40,000

ProVation EHR is an electronic health record designed for busy, cost-conscious Ambulatory Surgery Centers (ASCs). It offers electronic documentation and document imaging for all elements of the patient

Meda said that it markets a higher strength (5%) of imiquimod in Europe under the trademark Aldara. In 2009, sales of Aldara were approximately 500 MSEK. 3,75% imiquimod